Final results of ProGem1, the first in-human phase I/II study of NUC-1031 in patients with solid malignancies

File Description SizeFormat 
ProGeM1_final_res_ASCO2015.pdfPublished version93.61 kBAdobe PDFView/Open
Title: Final results of ProGem1, the first in-human phase I/II study of NUC-1031 in patients with solid malignancies
Authors: Blagden, SP
Rizzuto, I
Stavraka, C
O'Shea, D
Suppiah, P
Patel, M
Sukumaran, A
Loyse, N
Bharwani, N
Rockall, A
Gabra, H
El-Bahrawy, M
Wasan, H
Leonard, RCF
Habib, NA
Gribben, JG
Ghazaly, EA
McGuigan, C
Item Type: Conference Paper
Issue Date: 20-May-2015
Date of Acceptance: 1-May-2015
URI: http://hdl.handle.net/10044/1/50783
DOI: https://dx.doi.org/10.1200/jco.2015.33.15_suppl.2514
ISSN: 0732-183X
Publisher: American Society of Clinical Oncology
Journal / Book Title: Journal of Clinical Oncology
Volume: 33
Issue: 15
Copyright Statement: © 2015 American Society of Clinical Oncology. All rights reserved.
Conference Name: Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO)
Keywords: Science & Technology
Life Sciences & Biomedicine
Oncology
1112 Oncology And Carcinogenesis
Oncology & Carcinogenesis
Publication Status: Published
Start Date: 2015-05-29
Finish Date: 2015-06-02
Conference Place: Chicago, IL
Appears in Collections:Division of Surgery
Division of Cancer
Department of Medicine
Faculty of Medicine



Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

Creative Commonsx